286 related articles for article (PubMed ID: 29752428)
1. Angiopoietin-like protein 3 (ANGPTL3) deficiency and familial combined hypolipidemia.
Tarugi P; Bertolini S; Calandra S
J Biomed Res; 2019 Apr; 33(2):73-81. PubMed ID: 29752428
[TBL] [Abstract][Full Text] [Related]
2. Angiopoietin-like 3 in lipoprotein metabolism.
Kersten S
Nat Rev Endocrinol; 2017 Dec; 13(12):731-739. PubMed ID: 28984319
[TBL] [Abstract][Full Text] [Related]
3. Characterization of three kindreds with familial combined hypolipidemia caused by loss-of-function mutations of ANGPTL3.
Pisciotta L; Favari E; Magnolo L; Simonelli S; Adorni MP; Sallo R; Fancello T; Zavaroni I; Ardigò D; Bernini F; Calabresi L; Franceschini G; Tarugi P; Calandra S; Bertolini S
Circ Cardiovasc Genet; 2012 Feb; 5(1):42-50. PubMed ID: 22062970
[TBL] [Abstract][Full Text] [Related]
4. Genetic Mimicry Analysis Reveals the Specific Lipases Targeted by the ANGPTL3-ANGPTL8 Complex and ANGPTL4.
Landfors F; Chorell E; Kersten S
J Lipid Res; 2023 Jan; 64(1):100313. PubMed ID: 36372100
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological aspects of ANGPTL3 and ANGPTL4 inhibitors: New therapeutic approaches for the treatment of atherogenic dyslipidemia.
Ruscica M; Zimetti F; Adorni MP; Sirtori CR; Lupo MG; Ferri N
Pharmacol Res; 2020 Mar; 153():104653. PubMed ID: 31931117
[TBL] [Abstract][Full Text] [Related]
6. Angptl3 deficiency is associated with increased insulin sensitivity, lipoprotein lipase activity, and decreased serum free fatty acids.
Robciuc MR; Maranghi M; Lahikainen A; Rader D; Bensadoun A; Öörni K; Metso J; Minicocci I; Ciociola E; Ceci F; Montali A; Arca M; Ehnholm C; Jauhiainen M
Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1706-13. PubMed ID: 23661675
[TBL] [Abstract][Full Text] [Related]
7. Metabolomic Signature of Angiopoietin-Like Protein 3 Deficiency in Fasting and Postprandial State.
Tikkanen E; Minicocci I; Hällfors J; Di Costanzo A; D'Erasmo L; Poggiogalle E; Donini LM; Würtz P; Jauhiainen M; Olkkonen VM; Arca M
Arterioscler Thromb Vasc Biol; 2019 Apr; 39(4):665-674. PubMed ID: 30816800
[TBL] [Abstract][Full Text] [Related]
8. Familial combined hypolipidemia: angiopoietin-like protein-3 deficiency.
Arca M; D'Erasmo L; Minicocci I
Curr Opin Lipidol; 2020 Apr; 31(2):41-48. PubMed ID: 32022755
[TBL] [Abstract][Full Text] [Related]
9. Role of angiopoietin-like 3 (ANGPTL3) in regulating plasma level of low-density lipoprotein cholesterol.
Xu YX; Redon V; Yu H; Querbes W; Pirruccello J; Liebow A; Deik A; Trindade K; Wang X; Musunuru K; Clish CB; Cowan C; Fizgerald K; Rader D; Kathiresan S
Atherosclerosis; 2018 Jan; 268():196-206. PubMed ID: 29183623
[TBL] [Abstract][Full Text] [Related]
10. Genetically determined deficiency of ANGPTL3 does not alter HDL ability to preserve endothelial homeostasis.
Ossoli A; Minicocci I; Turri M; Di Costanzo A; D'Erasmo L; Bini S; Montavoci L; Veglia F; Calabresi L; Arca M
Biochim Biophys Acta Mol Cell Biol Lipids; 2023 Mar; 1868(3):159263. PubMed ID: 36521735
[TBL] [Abstract][Full Text] [Related]
11. Angiopoietin-like 3 inhibition of endothelial lipase is not modulated by angiopoietin-like 8.
Sylvers-Davie KL; Segura-Roman A; Salvi AM; Schache KJ; Davies BSJ
J Lipid Res; 2021; 62():100112. PubMed ID: 34461133
[TBL] [Abstract][Full Text] [Related]
12. ANGPTL8 promotes the ability of ANGPTL3 to bind and inhibit lipoprotein lipase.
Chi X; Britt EC; Shows HW; Hjelmaas AJ; Shetty SK; Cushing EM; Li W; Dou A; Zhang R; Davies BSJ
Mol Metab; 2017 Oct; 6(10):1137-1149. PubMed ID: 29031715
[TBL] [Abstract][Full Text] [Related]
13. The role of ANGPTL3 in controlling lipoprotein metabolism.
Tikka A; Jauhiainen M
Endocrine; 2016 May; 52(2):187-93. PubMed ID: 26754661
[TBL] [Abstract][Full Text] [Related]
14. Angiopoietin-like 3: An important protein in regulating lipoprotein levels.
Burks KH; Basu D; Goldberg IJ; Stitziel NO
Best Pract Res Clin Endocrinol Metab; 2023 May; 37(3):101688. PubMed ID: 35999139
[TBL] [Abstract][Full Text] [Related]
15. Differential association of plasma angiopoietin-like proteins 3 and 4 with lipid and metabolic traits.
Mehta N; Qamar A; Qu L; Qasim AN; Mehta NN; Reilly MP; Rader DJ
Arterioscler Thromb Vasc Biol; 2014 May; 34(5):1057-63. PubMed ID: 24626437
[TBL] [Abstract][Full Text] [Related]
16. Clinical and biochemical characteristics of individuals with low cholesterol syndromes: A comparison between familial hypobetalipoproteinemia and familial combined hypolipidemia.
Di Costanzo A; Di Leo E; Noto D; Cefalù AB; Minicocci I; Polito L; D'Erasmo L; Cantisani V; Spina R; Tarugi P; Averna M; Arca M
J Clin Lipidol; 2017; 11(5):1234-1242. PubMed ID: 28733173
[TBL] [Abstract][Full Text] [Related]
17. Threshold Effects of Circulating Angiopoietin-Like 3 Levels on Plasma Lipoproteins.
Fazio S; Minnier J; Shapiro MD; Tsimikas S; Tarugi P; Averna MR; Arca M; Tavori H
J Clin Endocrinol Metab; 2017 Sep; 102(9):3340-3348. PubMed ID: 28633452
[TBL] [Abstract][Full Text] [Related]
18. New insights into ANGPLT3 in controlling lipoprotein metabolism and risk of cardiovascular diseases.
Su X; Peng DQ
Lipids Health Dis; 2018 Jan; 17(1):12. PubMed ID: 29334984
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of ANGPTL3 reduces hepatic VLDL-triglyceride secretion.
Wang Y; Gusarova V; Banfi S; Gromada J; Cohen JC; Hobbs HH
J Lipid Res; 2015 Jul; 56(7):1296-307. PubMed ID: 25954050
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]